Latest Market News

Strategic Elements Limited is raising up to $1 million via a Share Purchase Plan (SPP) at 3.5 cents per share, with attaching options exercisable at 4 cents, to fuel development in Energy Ink™ and Stealth Technologies.

Ex-CEO Geoff Cockerill has initiated court proceedings against Vitura Limited, alleging breaches of the Fair Work Act related to his January 2026 departure. Vitura maintains all contractual obligations were met and plans to resolve the dispute swiftly.

Close the Loop Limited has sold its ISP Tek Services business for US$10 million, slashed US$16 million of debt, and set an optimistic EBITDA target of $14 million to $16 million for FY27, signalling a sharper focus on its packaging and resource recovery strengths.

Patrys has appointed CMAX and Alithia Life Sciences to lead its Phase 1A clinical trial operations for RLS-2202, advancing its injectable quetiapine program toward first-in-human testing in Q3 2026, pending ethics approval.

Thrive Tribe Technologies (ASX:1TT) is issuing approximately 116.87 million Loyalty Options to shareholders at no cost, exercisable at $0.003 each and expiring in 2029, aiming to reward loyalty and potentially raise capital upon exercise.

Cleo Diagnostics has laid out a clear U.S. reimbursement pathway for its ovarian cancer test, leveraging an existing CPT code to enable early market entry and data collection ahead of FDA clearance.

Hydrix Limited has bolstered its balance sheet by raising $3.89 million and converting $5.1 million of debt into equity, positioning itself to expand its Defence technology footprint following a $1.2 million contract with NIOA Group.

IMEXHS Limited exceeded FY25 revenue and EBITDA guidance, driven by strategic contract wins and AI-powered workflow automation. The company projects stronger software growth and sustained profitability in FY26.

EBR Systems has locked in a three-year purchasing agreement with CHRISTUS Health, the ninth-largest US hospital network, to advance its WiSE CRT System's US rollout across 66 hospitals.

OncoSil Medical has clinched TGA approval for its OncoSil™ device, the first Class III medical device targeting pancreatic tumours in Australia, paving the way for local commercialisation and enhanced patient access.

GenusPlus is set to transform its business with a $400 million acquisition of MPC Kinetic, diversifying into gas and water sectors and boosting earnings per share by nearly 60%. The deal is backed by a $200 million placement and expanded debt facilities.

Redcastle Resources has secured A$2 million through a discounted share placement aimed at accelerating exploration and advancing its development projects across its Eastern Goldfields portfolio.